Advanced age is not a barrier to creating a functional arteriovenous fistula: a retrospective study

医学 回顾性队列研究 动静脉瘘 瘘管 血液透析 队列 糖尿病 单中心 外科 内科学 内分泌学
作者
Monica Beaulieu,Chance S. Dumaine,Alexandra Romann,Mercedeh Kiaii
出处
期刊:Journal of Vascular Access [SAGE Publishing]
卷期号:18 (4): 307-312 被引量:11
标识
DOI:10.5301/jva.5000710
摘要

Introduction Arteriovenous fistulas (AVFs) are the recommended form of vascular access for hemodialysis. However, controversy exists regarding whether AVFs are suitable for elderly patients. Methods Single-center retrospective review to investigate the impact of age on AVF outcomes. Five hundred and twenty-five patients with AVF creation were stratified based on age <65, 65-75, and >75 years. AVF outcomes including primary failure, AVF patency (primary, secondary, and functional), and AVF complications were studied for 3 years following AVF creation. Results The cohort was 63% male, 44% Caucasian, and 55% had diabetes or cardiovascular disease. 39% were aged <65 years, 33% 65-75 years, and 28% were aged >75 years. No differences in rates of primary failure, loss of primary patency, complications, or need for intervention were observed between age groups. There was a significant association of age with secondary patency and functional patency, with age >75 being an independent risk factor for shortened lifespan of the fistula. For patients aged >75 years, secondary patency at 3 years was 64% compared to 75%-78% for younger patients. Functional patency at 2 years was 69% for those aged >75 years compared to 78%-81% for younger patients. Conclusions We found no difference in AVF maturation, primary patency, complications, or interventions in those over the age of 75 compared to younger counterparts. While secondary and functional patency rates were significantly lower in those aged >75 years, the magnitude of difference is likely not clinically relevant. Therefore, we recommend that advanced age alone should not preclude patients from AVF creation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zsj完成签到,获得积分10
刚刚
美满的泥猴桃完成签到,获得积分10
刚刚
勤奋幻柏完成签到,获得积分10
刚刚
蓉儿完成签到 ,获得积分10
刚刚
小稻草人应助xyzlancet采纳,获得10
1秒前
无辜秋珊完成签到,获得积分20
1秒前
LIXI发布了新的文献求助10
1秒前
蔬菜土豆完成签到,获得积分20
1秒前
柳煜城完成签到,获得积分10
2秒前
2秒前
2秒前
饿哭了塞完成签到 ,获得积分10
2秒前
大橘完成签到 ,获得积分10
3秒前
55完成签到,获得积分10
3秒前
无欲无求傻傻完成签到,获得积分10
4秒前
图图应助勤恳祥采纳,获得10
4秒前
舒服的踏歌完成签到,获得积分10
4秒前
奥斯卡完成签到,获得积分10
4秒前
白白完成签到,获得积分10
5秒前
自由的明雪完成签到,获得积分10
5秒前
明理小霸王完成签到,获得积分10
5秒前
Yeong完成签到,获得积分10
6秒前
寻舟者完成签到,获得积分10
6秒前
霸气曼彤发布了新的文献求助10
6秒前
现代风格完成签到,获得积分10
7秒前
魏白晴完成签到,获得积分10
7秒前
愉快寒香完成签到,获得积分10
8秒前
xiaodong完成签到,获得积分10
8秒前
xu发布了新的文献求助10
9秒前
研友_QQC完成签到,获得积分10
10秒前
10秒前
10秒前
LIXI完成签到,获得积分10
10秒前
快乐的忆山完成签到,获得积分10
10秒前
愉快寒香发布了新的文献求助10
11秒前
12秒前
sjyu1985完成签到,获得积分10
12秒前
天才幸运鱼完成签到,获得积分10
12秒前
郝老头完成签到,获得积分10
13秒前
14秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
Residual Stress Measurement by X-Ray Diffraction, 2003 Edition HS-784/2003 588
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3950021
求助须知:如何正确求助?哪些是违规求助? 3495367
关于积分的说明 11076612
捐赠科研通 3225910
什么是DOI,文献DOI怎么找? 1783346
邀请新用户注册赠送积分活动 867609
科研通“疑难数据库(出版商)”最低求助积分说明 800855